Mavroudis D, Saloustros E, Malamos N, Kakolyris S, et al. Corrigendum to Six versus 12 months of adjuvant trastuzumab in combination with
dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter
randomized study by the Hellenic Oncology Research Group (HORG): Annals of
Oncology, Volu Ann Oncol 2020;31:444-445.
PMID: 32067691